T-DM1

10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer
Yahoo/BusinessWire
Sat, 12/11/10 - 11:48 am
Immunogen
T-DM1
Pertuzumab
breast cancer
HER2 Inhibitor
trastuzumab
Immunogen's T-DM1 Gets Presidential Treatment
Seeking Alpha
Sun, 10/3/10 - 11:48 am
Immunogen
T-DM1
breast cancer
Breast Cancer Drug T-DM1 Expected To Deliver Exciting Data In First Half Of 2010; Roche Expected To File For NDA
Yahoo/Wall St. Transcript
Sat, 04/10/10 - 03:01 pm
T-DM1
Roche
breast cancer

Pages